Intrathecal Drug Delivery for Pain: A Clinical Guide and Future Directions

References

• Deer TR , PragerJ , LevyRet al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel . Neuromodulation15 ( 5 ), 436 – 464 ( 2012 ). Discussion 464–466 .
   PubMed Web of Science ®Google Scholar
• Smith TJ , StaatsPS , DeerTet al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival . J. Clin. Oncol.20 ( 19 ), 4040 – 4049 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Battal B , KocaogluM , BulanskiNet al. Cerebrospinal fluid flow imaging by using phase-contrast MR technique . Br. J. Radiol.84 ( 1004 ), 758 – 765 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bulat M , KlaricaM . Recent insights into the hydrodymanics of the cerebrospinal fluid . Brain Res. Rev.65 ( 2 ), 99 – 112 ( 2011 ).
   PubMedGoogle Scholar
• Henry-Feugeas MC , Idy-PerettiI , BaledentOet al. Origin of subarachnoid cerebrospinal fluid pulsations: a phase-contrast MR analysis . Magn. Reson. Imaging18 ( 4 ), 387 – 395 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Friese S , HamhaberU , ErbM , KuekerW , KlsoeU . The influence of pulse and respiration on spinal cerebrospinal fluid pulsation . Invest. Radiol.39 ( 2 ), 120 – 130 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Stockman HW . Effect of anatomic fine structure on the flow of cerebrospinal fluid in the spinal subarachnoid space . J. Biomech. Eng.128 ( 1 ), 106 – 114 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Degrell I , NagyE . Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid . Biol. Psychiatry27 ( 8 ), 891 – 896 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Bernards CM . Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs . Anesthesiology105 ( 1 ), 169 – 178 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Flack SH , BernardsCM . Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs . Anesthesiology112 ( 1 ), 165 – 175 ( 2011 ).
   Web of Science ®Google Scholar
• Flack SH , AndersonCM , BernardsC . Morphine distribution in the spinal cord after chronic infusion in pigs . Anesth. Analg.112 ( 2 ), 460 – 464 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hejtmanek MR , HarveyTD , BernardsCM . Measured density and calculated baricity of custom-compounded drugs for chronic intrathecal infusion . Reg. Anesth. Pain Med.36 ( 1 ), 7 – 11 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yaksh TL , de KaterA , DeanR , BestBM , MiljanichGP . Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in dog . Neuromodulation15 ( 6 ), 508 – 519 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pope JE , DeerTR . Ziconotide: a clinical update and pharmacologic review . Expert Opin. Pharmacother.14 ( 7 ), 957 – 966 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guide to Implant Devices for Intrathecal Therapy . http://www.practicalpainmanagement.com/treatments/interventional/pumps/guide-implantable-devices-intrathecal-therapy .
   Google Scholar
• Medtronic Model 8637 SynchroMed II Implantable Infusion Pump . http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm271492.htm .
   Google Scholar
• Prometra® Programmable Infusion Pump System - P080012 . http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm293502.htm .
   Google Scholar
• Rauck R , DeerT , RosenSet al. Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra Programmable Pump . Neuromodulation13 ( 2 ), 102 – 108 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Saulino M , GofeldM . “Sonology” of Programmable Intrathecal Pumps.. (Year) . [ Neuromodulation17 ( 7 ), 696 – 698 ( 2014 ; discussion 698 . DOI: 10.1111/ner.12159 . ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Deer TR , PragerJ , LevyRet al. Polyanalgesic Consensus Conference‐‐2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel . Neuromodulation15 ( 5 ), 420 – 435 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Westenbroek RE , HoslinsL , CattarallWA . Localization of Ca 2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals . J. Neurosci.18 ( 16 ), 6319 – 6330 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Veizi IE , HayekSM , NarouzeS , PopeJE , MekhailN . Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients . Pain Med.12 ( 10 ), 1481 – 1489 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Deer TR , CarawayDL , KimCK , DempseyCD , StewartCD , McNeilKF . Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic pain of the spine . Spine J.2 ( 4 ), 274 – 278 ( 2002 ).
   PubMedGoogle Scholar
• Medtronic SynchroMed II Implantable Drug Infusion Pump and SynchroMed EL Implantable Drug Infusion Pump . http://www.fda.gov/MedicalDevices/Safety/ucm333231.htm .
   Google Scholar
• Shields DE , AclanJ , SzatkowskiA . Chemical stability of admixtures containing 25 mcg/mL ziconotide and 10 mg/mL or 20 mg/mL morphine sulfate during simulated intrathecal administration . Int. J. Pharm. Compd.12 ( 6 ), 552 – 557 ( 2008 ).
   Google Scholar
• Shields D , MontenegroR , RagusaM . Chemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration . Neuromodulation8 ( 4 ), 257 – 263 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Shields D , MontenegroR , AclanJ . Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration . Neuromodulation10 ( 1 ), 12 – 17 ( 2007 ).
   PubMedGoogle Scholar
• Shields D , MontenegroR . Chemical stability of ziconotide–clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration . Neuromodulation10 ( 1 ), 6 – 11 ( 2007 ).
   PubMedGoogle Scholar
• Shields D , MontenegroR , AclanJ . Chemical stability of an admixture combining ziconotide and bupivacaine during simulated intrathecal administration . Neuromodulation10 ( 1 ), 1 – 5 ( 2007 ).
   PubMedGoogle Scholar
• Shields DE , AclanJ , SzatkowskiA . Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration . Int. J. Pharm. Compd.12 ( 5 ), 463 – 466 ( 2008 ).
   PubMedGoogle Scholar
• Pope JE , DeerTR , AmirdelfanK , KapuralL , VerrillsP . New concepts for waveform and current delivey for spinal cord stimulation: burst and high frequency . Minimally Invasive Surgery for Pain ( 2015 ) ( Epub ahead of print ).
   Google Scholar
• Pope JE , FalowskiS , DeerTR . Advanced waveforms and frequency with spinal cord stimulation: burst and high frequency energy delivery . Expert Rev. Med. Devices . DOI:10.1586/17434440.2015.1026805 ( 2015 ) ( Epub ahead of Print ).
   PubMed Web of Science ®Google Scholar
• Van Buyten JP , Al-KaisyA , SmetI , PalmisaniS , SmithT . High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective multicenter European clinical study . Neuromodulation16 ( 1 ), 59 – 65 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Al-Kaisy A , Van BuytenJP , SmetI , PalmisaniS , PangD , SmithT . Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study . Pain Med.15 ( 3 ), 347 – 354 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tiede J , BrownL , GekhtG , VallejoR , YearwoodT , MorganD . Novel spinal cord stimulation parameters in patients with predominant back pain . Neuromodulation16 ( 4 ), 370 – 375 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liem L , RussoM , HuygenFJet al. A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic pain . Neuromodulation16 ( 5 ), 471 – 482 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Deer TR . A critical time for practice change in the pain treatment continuum: we need to reconsider the role of pumps in the patient care algorithm . Pain Med.11 ( 7 ), 987 – 989 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kumar K , HunterG , DemeriaD . Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience . Neurosurgery58 ( 3 ), 481 – 496 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Deer TR , SmithHS , CousinsMet al. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery . Pain Physician13 ( 3 ), E175 – E213 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mohammed SI , EldabeS , SimpsonKHet al. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study . Neuromodulation16 ( 6 ), 576 – 581 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Coffey RJ , OwensML , BrosteSKet al. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain . Anesthesiology111 ( 4 ), 881 – 891 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gofeld M , McQueenCK . Ultrasound-guided intrathecal pump access and prevention of the pocket fill . Pain Med.12 ( 4 ), 607 – 611 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pope JE , McRobertsP , DeerTR . Randomized, prospective study to assess the safety of a novel intrathecal bolus-only delivery strategy as compared to traditional simple slow continuous delivery . Presented at : North American Neuromodulation Society 18th Annual Meeting , Las Vegas (NV), USA , 11 – 14 ( December 2014 ).
   Google Scholar
• Pope JE , DeerTR . Intrathecal pharmacology update: novel dosing strategy for intrathecal monotherapy ziconotide on efficacy and sustainability . Neuromodulation24 . DOI: 10.1111/ner.12274 ( 2015 ) ( Epub ahead of print ).
   Google Scholar